US Patent

US8268800 — Certain compounds, compositions and methods

Method of Use · Assigned to Eisai Inc · Expires 2030-08-22 · 4y remaining

Vulnerability score 68/100 Moderate — design-around opportunities exist

What this patent protects

This patent protects certain tetrahydrouridine derivative compounds, pharmaceutical compositions, and kits, as well as methods of making and using these compounds.

USPTO Abstract

The present invention provides certain tetrahydrouridine derivative compounds, pharmaceutical compositions and kits comprising such compounds, and methods of making and using such compounds.

Drugs covered by this patent

FDA Patent Use Codes

When a patent is method-of-use, FDA lists it once per applicable indication ("U-code"). Each U-code carves out a specific therapeutic use that generic filers must either license or design around.

CodeDescriptionDrug
U-2866 cedazuridine

Patent Metadata

Patent number
US8268800
Jurisdiction
US
Classification
Method of Use
Expires
2030-08-22
Drug substance claim
Yes
Drug product claim
No
Assignee
Eisai Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.